Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development	$ 23,758	$ 12,944	$ 68,789	$ 33,440
General and administrative	7,540	5,356	22,282	13,202
Total operating expenses	31,298	18,300	91,071	46,642
Loss from operations	(31,298)	(18,300)	(91,071)	(46,642)
Other income (expense), net:
Interest income	596	23	917	41
Other income (expense), net	6	15	5	31
Total other income (expense), net	602	38	922	72
Net loss before income tax expense	(30,696)	(18,262)	(90,149)	(46,570)
Net loss	(30,696)	(18,262)	(90,149)	(46,570)
Other comprehensive loss:
Net unrealized loss on marketable securities	(28)	(23)	(626)	(23)
Comprehensive loss	$ (30,724)	$ (18,285)	$ (90,775)	$ (46,593)
Net loss per share, basic	$ (0.74)	$ (0.68)	$ (2.18)	$ (4.75)
Net loss per share, diluted	$ (0.74)	$ (0.68)	$ (2.18)	$ (4.75)
Weighted-average shares used in computing net loss per share, basic	41,358,296	26,895,716	41,309,812	9,808,162
Weighted-average shares used in computing net loss per share, diluted	41,358,296	26,895,716	41,309,812	9,808,162